Hunan Er-kang Pharmaceutical Co., Ltd.
尔康制药
300267
Shenzhen Stock Exchange
Company Profile
AS the first company to introduce Pharmaceutical GMP Standards to the production of pharmaceutical excipients, Er—Kang owns advanced testing & inspection devices such as LC-MS, GCMS, preparative chromatograph, atomic absorption spectrometer, multi-functional reaction device, etc. In addition, the company has built a long-term Industry-University-Research partnership with 10 universities and research institutes, including China Pharmaceutical University, Central South University, and Shanghai Pharmaceutical Research Institute. As the supporting unit of "National Research Center of Pharmaceutical Excipients Engineering Technology", Er Kang was recognized as “Key High-Tech Enterprise in National Torch Plan “by the National Ministry of Science and Technology. The company's Technology Center was granted as “State Recognized Enterprise Technology Center “and "National Model Expert Workstation" by the National Development and Reform Commission and China Science and Technology Association respectively. Up to December 31st 2022，Er-Kang has 195 patents which including 11 overseas patents.
Full description
Hunan Er-Kang Pharmaceutical Co., Ltd (Stock#300267), founded in October 2003, boasts the largest leading enterprise in pharmaceutical excipient industry.Er-Kang was listed in Shenzhen Stock Exchange on Sep. 27th, 2011, being the only first listed company in the industry.Up to December 31st 2020, it owns 73 API products, 127 pharmaceutical excipients and Drug Approvals for 282 finished medicine products, forming a new development mode which focuses on three key products of API, finished medicine product, and pharmaceutical excipients. ER-Kang’s business covers 30 local provinces and autonomous regions, Southeast Asia, Europe, and the North America, with 15 regional offices /distribution centers nationwide.Adhering to the policy of "Drug Safety Above Everything ", Er-Kang consistently takes product quality as lifeline and introduces GMP standards into the production of pharmaceutical excipients for the first time. It now owns multiple state-of-the-art pharmaceutical production lines, internationally advanced drug test devices, and a top-class R & D center with a professional team.Er-Kang is recognized as "National Torch Plan Key High-Tech Enterprise" and the supporting unit of China’s first “State-Level R&D” by National Ministry of Science and Technology.The company successfully break through the technical bottleneck of new-type high-end starch capsules, and, through a series of optimal integration of domestic and international resources, established a complete industrial chain from raw material upstream to production and end-user market, becoming the world's first cassava starch manufacturer.The company is now registered with FDA and filed the DMF of starch capsule and obtained multiple certificates like Halal by IFANCA, Halal by MUI Indonesia, and Kosher by KOF-K, etc. Taking the revitalization of national pharmaceutical excipients industry as its lofty responsibility, Er-Kang will constantly develop new blueprint through pharmaceutical innovation and work with the peers in the industry on win-win basis in the future.